Bormioli Rocco moving towards the US pharma market.
Bormioli Rocco Pharma reestablishes its committment to build on its position in the US Pharma market through intensive trade shows planning, including DCAT Week Ã17, PDA Annual Meeting, CPhI North America and Contract Pharma.
Andrea Fulvi, Sales Director, briefly describes the underlying strategy.
“This program supports a broader commercial strategy focused on the US market and aimed to strongly associate the company brand with the high quality of its borosilicate glass and its strong focus on business development.†For the company the US represents a high value market with an expected steady growth in the demand for parenteral containers, mainly driven by biologics and biosimilar increased volumes. In addition, the regulatory environment is becoming more and more stringent, encouraging pharma companies to choose highly qualified packaging suppliers. In such a context, we believe that new interesting business opportunities will arise.”
As part of this strategy, from March 20 to March 23 Bormioli Rocco Pharma will participate in DCAT Week Ã17, New York. The event is globally recognized as a unique occasion for both pharma companies and suppliers for networking, strengthening relationships and creating development synergies. This is why Bormioli Rocco Pharma decided to affirm its presence on the event, becoming one of the major sponsors of the DCAT Annual Gala Dinner.